Interestingly, accumulating evidence suggests there may be sex differences in efficacy of cholinesterase inhibitor treatment with some studies reporting that cholinesterase inhibitors may delay AD progression during the prodromal stages more efficaciously in women than men (Ferretti et al., 2018). Here, BCHE is linked to Alzheimer disease.